DATABASE

ABCDEFGHIJKLMNOPQRSTUVWXYZ


Name Category
CYTORI THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition News
CYTORI THERAPEUTICS, INC. Financials News
Cytori to Present at Regen Med Investor Day 2013 on April 17 News
Cytori to Webcast at the Future Leaders in the Biotech Industry Conference on April 5, 2013 News
Cytori to Webcast First Quarter Financial Results on May 9 News
Cytori’s Stem Cell Therapy for Burns Wins U.S. Contract News
CytoSorbents Announces Trauma Advisory Board News
CytoSorbents Appoints Christopher Cramer as Vice President of Business Development News
CytoSorbents Awarded Additional Phase I Option on US Army SBIR Trauma Contract News
CytoSorbents CEO Provides Exclusive Interview With medGadget News
CYTOSORBENTS CORP Files SEC form 10-K, Annual Report News
CYTOSORBENTS CORP Files SEC form 10-Q, Quarterly Report News
CYTOSORBENTS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits News
CYTOSORBENTS CORP Financials News
Cytosorbents Corporation Fund
CytoSorbents Enters Into Exclusive Distribution Agreement for CytoSorb(R) With L.IN.C. Medical Systems in the United Kingdom and Ireland News
CytoSorbents Featured in MedCity News News
CytoSorbents Provides Corporate Update and Reports 2012 Year End Financial Results News
CytoSorbents Reports 2013 First Quarter Financial Results News
CytoSorbents to Exhibit at the ISICEM 2013 Critical Care Conference News
CytoSorbents to Present at the Long Island Capital Alliance Health Care Capital Forum on March 8, 2013 News
CytoTools AG Fund
CytRx Announces Agreement with FDA on Special Protocol Assessment for Global Pivotal Phase 3 Clinical Trial with Aldoxorubicin for Soft Tissue Sarcoma News
CytRx announces data from Phase 1b trial of aldoxorubicin News
CytRx Announces Initial Results from Pharmacokinetics Clinical Trial with Aldoxorubicin in Solid Tumors News
Page 1068 of 1069